Event dossier

J&J drug Erleada reduces risk of prostate cancer spread, death

Erleada reduced the risk of the cancer spreading or death by 20 per cent. Grouped from 2 articles across 2 sources.

2 reports2 sourcesMay 31, 2026, 2:34 PM
FilterThe Straits Times
Clustered coverageCNBC, The Straits Times
Coverage timeline2
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

The Straits TimesMay 31, 2026, 2:34 PM

J&J drug Erleada reduces risk of prostate cancer spread, death

Erleada reduced the risk of the cancer spreading or death by 20 per cent.

CNBCMay 31, 2026, 12:00 PM

A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China

An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo